Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
HKSE - Delayed Quote HKD

MODERN CHI MED (1643.HK)

Compare
0.400
+0.005
+(1.27%)
At close: 3:57:11 PM GMT+8

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Ms. Xinlei Sun Executive Chairman 43.93k -- 1986
Ms. Hongli Zhang CEO & Executive Director 308.61k -- 1965
Ms. Yanru Jia Joint Company Secretary & Executive Director 31.07k -- 1984
Mr. Wen Tao Li Chief Financial Officer -- -- 1983
Ms. Tsz Hei Chan Joint Company Secretary -- -- 1986

MODERN CHI MED

No. 88, Jinwei Road
Longhua County
Chengde, 067000
China
86 31 4716 2222 https://www.cdysjdyy.com
Sector: 
Healthcare
Full Time Employees: 
190

Description

Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. The company offers vigour and vitality supplement, circulation enhancement, kidney invigoration, menstrual discomfort relief, huoxiang zheng qi, liver-dispersing and stomach regulating, and fever- removing and detoxification pills; cardiotonic enhancement and heart wellness capsules; and liver detox tablets. It offers its products as therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and respiratory system conditions. It also provides business support, technical, and consulting services. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.

Corporate Governance

MODERN CHI MED’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 25, 2022 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers